Document is current
Any future updates will be listed below
-
Authors
Mukherjee, R.
Muehlemann, N.
Gao, Y.
Stone, Gregg W.
Mehta, C.
- License Information
-
More Information
Article History
Received: 16 July 2025
Accepted: 8 August 2025
First Online: 16 August 2025
Declarations
:
: Y.G. is an employee of Abiomed.N.M., C.M are employee of Cytel Inc. R.M. was an employee of Cytel at the time of this project. Cytel has a research service contract with Abiomed.Dr. Stone has received speaker honoraria from Medtronic, Amgen, Boehringer Ingelheim; has served as a consultant to Robocath, Daiichi Sankyo, Vectorious, Miracor, Apollo Therapeutics, Cardiac Success, Occlutech, Millennia Biopharma, Ablative Solutions, Oxitope, Impulse Dynamics, Remote Cardiac Enablement, Valfix, Zoll, HeartFlow, Shockwave, Adona Medical, Abbott, HighLife, Elixir, Elucid Bio, Aria, Alleviant, FBR Medical, Myochron, Colibri; and has equity/options from Cardiac Success, Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Valfix, Xenter. Dr. Stone’s employer, Mount Sinai Hospital, receives research grants from Shockwave, Biosense-Webster, Bioventrix, Abbott, Abiomed, Cardiovascular Systems Inc, Phillips, Vascular Dynamics, Pulnovo, V-wave and PCORI (via Weill Cornell Medical Center).
